nodes	percent_of_prediction	percent_of_DWPC	metapath
Sodium stibogluconate—Venous thrombosis—Carboplatin—bone cancer	0.0528	0.0529	CcSEcCtD
Sodium stibogluconate—Fluid overload—Carboplatin—bone cancer	0.0459	0.0459	CcSEcCtD
Sodium stibogluconate—Extravasation—Carboplatin—bone cancer	0.0327	0.0327	CcSEcCtD
Sodium stibogluconate—Haemolysis—Cisplatin—bone cancer	0.0263	0.0264	CcSEcCtD
Sodium stibogluconate—Tetany—Cisplatin—bone cancer	0.0257	0.0257	CcSEcCtD
Sodium stibogluconate—Phlebitis—Carboplatin—bone cancer	0.024	0.0241	CcSEcCtD
Sodium stibogluconate—Venous thrombosis—Cisplatin—bone cancer	0.0155	0.0155	CcSEcCtD
Sodium stibogluconate—Faecaloma—Epirubicin—bone cancer	0.015	0.0151	CcSEcCtD
Sodium stibogluconate—Faecalith—Epirubicin—bone cancer	0.015	0.0151	CcSEcCtD
Sodium stibogluconate—Faecaloma—Doxorubicin—bone cancer	0.0139	0.0139	CcSEcCtD
Sodium stibogluconate—Faecalith—Doxorubicin—bone cancer	0.0139	0.0139	CcSEcCtD
Sodium stibogluconate—Warmth—Epirubicin—bone cancer	0.0135	0.0135	CcSEcCtD
Sodium stibogluconate—Fluid overload—Cisplatin—bone cancer	0.0135	0.0135	CcSEcCtD
Sodium stibogluconate—Hyperphosphataemia—Epirubicin—bone cancer	0.0126	0.0126	CcSEcCtD
Sodium stibogluconate—Warmth—Doxorubicin—bone cancer	0.0125	0.0125	CcSEcCtD
Sodium stibogluconate—Hyperphosphataemia—Doxorubicin—bone cancer	0.0116	0.0117	CcSEcCtD
Sodium stibogluconate—Intestinal perforation—Methotrexate—bone cancer	0.0116	0.0116	CcSEcCtD
Sodium stibogluconate—Necrosis—Cisplatin—bone cancer	0.0107	0.0107	CcSEcCtD
Sodium stibogluconate—Abscess—Cisplatin—bone cancer	0.0106	0.0106	CcSEcCtD
Sodium stibogluconate—Infection—Carboplatin—bone cancer	0.0101	0.0101	CcSEcCtD
Sodium stibogluconate—Tenderness—Cisplatin—bone cancer	0.00959	0.00961	CcSEcCtD
Sodium stibogluconate—Extravasation—Cisplatin—bone cancer	0.00959	0.00961	CcSEcCtD
Sodium stibogluconate—Cellulitis—Cisplatin—bone cancer	0.0092	0.00922	CcSEcCtD
Sodium stibogluconate—Ulcer—Cisplatin—bone cancer	0.00884	0.00886	CcSEcCtD
Sodium stibogluconate—Hypernatraemia—Epirubicin—bone cancer	0.00817	0.00819	CcSEcCtD
Sodium stibogluconate—Body temperature increased—Carboplatin—bone cancer	0.00804	0.00806	CcSEcCtD
Sodium stibogluconate—Venous thrombosis—Epirubicin—bone cancer	0.00796	0.00797	CcSEcCtD
Sodium stibogluconate—Fluid retention—Cisplatin—bone cancer	0.00794	0.00796	CcSEcCtD
Sodium stibogluconate—Hypernatraemia—Doxorubicin—bone cancer	0.00756	0.00757	CcSEcCtD
Sodium stibogluconate—Venous thrombosis—Doxorubicin—bone cancer	0.00736	0.00738	CcSEcCtD
Sodium stibogluconate—Phlebitis—Cisplatin—bone cancer	0.00705	0.00706	CcSEcCtD
Sodium stibogluconate—Cardiac failure congestive—Cisplatin—bone cancer	0.0067	0.00671	CcSEcCtD
Sodium stibogluconate—Renal failure acute—Cisplatin—bone cancer	0.00658	0.00659	CcSEcCtD
Sodium stibogluconate—Cyanosis—Methotrexate—bone cancer	0.00649	0.0065	CcSEcCtD
Sodium stibogluconate—Lung disorder—Methotrexate—bone cancer	0.00649	0.0065	CcSEcCtD
Sodium stibogluconate—Cerebrovascular accident—Cisplatin—bone cancer	0.0062	0.00621	CcSEcCtD
Sodium stibogluconate—Hyponatraemia—Cisplatin—bone cancer	0.0061	0.00611	CcSEcCtD
Sodium stibogluconate—Lung disorder—Epirubicin—bone cancer	0.00607	0.00608	CcSEcCtD
Sodium stibogluconate—Necrosis—Methotrexate—bone cancer	0.00585	0.00586	CcSEcCtD
Sodium stibogluconate—Abscess—Methotrexate—bone cancer	0.0058	0.00581	CcSEcCtD
Sodium stibogluconate—Irritability—Cisplatin—bone cancer	0.0058	0.00581	CcSEcCtD
Sodium stibogluconate—Blood creatinine increased—Cisplatin—bone cancer	0.00569	0.0057	CcSEcCtD
Sodium stibogluconate—Dehydration—Cisplatin—bone cancer	0.00565	0.00566	CcSEcCtD
Sodium stibogluconate—Lung disorder—Doxorubicin—bone cancer	0.00562	0.00563	CcSEcCtD
Sodium stibogluconate—Hypokalaemia—Cisplatin—bone cancer	0.00553	0.00554	CcSEcCtD
Sodium stibogluconate—Feeling hot—Epirubicin—bone cancer	0.00547	0.00548	CcSEcCtD
Sodium stibogluconate—Necrosis—Epirubicin—bone cancer	0.00547	0.00548	CcSEcCtD
Sodium stibogluconate—Abscess—Epirubicin—bone cancer	0.00543	0.00544	CcSEcCtD
Sodium stibogluconate—Extravasation—Methotrexate—bone cancer	0.00526	0.00527	CcSEcCtD
Sodium stibogluconate—Sweating increased—Cisplatin—bone cancer	0.00511	0.00512	CcSEcCtD
Sodium stibogluconate—Necrosis—Doxorubicin—bone cancer	0.00506	0.00507	CcSEcCtD
Sodium stibogluconate—Feeling hot—Doxorubicin—bone cancer	0.00506	0.00507	CcSEcCtD
Sodium stibogluconate—Abscess—Doxorubicin—bone cancer	0.00502	0.00503	CcSEcCtD
Sodium stibogluconate—Oliguria—Methotrexate—bone cancer	0.00498	0.00499	CcSEcCtD
Sodium stibogluconate—Extravasation—Epirubicin—bone cancer	0.00492	0.00493	CcSEcCtD
Sodium stibogluconate—Ulcer—Methotrexate—bone cancer	0.00485	0.00486	CcSEcCtD
Sodium stibogluconate—Cellulitis—Epirubicin—bone cancer	0.00472	0.00473	CcSEcCtD
Sodium stibogluconate—Hypocalcaemia—Epirubicin—bone cancer	0.00469	0.0047	CcSEcCtD
Sodium stibogluconate—Oliguria—Epirubicin—bone cancer	0.00466	0.00467	CcSEcCtD
Sodium stibogluconate—Acute coronary syndrome—Cisplatin—bone cancer	0.00461	0.00462	CcSEcCtD
Sodium stibogluconate—Renal failure—Cisplatin—bone cancer	0.0046	0.00461	CcSEcCtD
Sodium stibogluconate—Myocardial infarction—Cisplatin—bone cancer	0.00459	0.0046	CcSEcCtD
Sodium stibogluconate—Extravasation—Doxorubicin—bone cancer	0.00456	0.00456	CcSEcCtD
Sodium stibogluconate—Ulcer—Epirubicin—bone cancer	0.00454	0.00455	CcSEcCtD
Sodium stibogluconate—Creatinine increased—Epirubicin—bone cancer	0.00451	0.00452	CcSEcCtD
Sodium stibogluconate—Cellulitis—Doxorubicin—bone cancer	0.00437	0.00438	CcSEcCtD
Sodium stibogluconate—Hypocalcaemia—Doxorubicin—bone cancer	0.00434	0.00435	CcSEcCtD
Sodium stibogluconate—Oliguria—Doxorubicin—bone cancer	0.00431	0.00432	CcSEcCtD
Sodium stibogluconate—Ulcer—Doxorubicin—bone cancer	0.0042	0.00421	CcSEcCtD
Sodium stibogluconate—Creatinine increased—Doxorubicin—bone cancer	0.00418	0.00418	CcSEcCtD
Sodium stibogluconate—Fluid retention—Epirubicin—bone cancer	0.00408	0.00409	CcSEcCtD
Sodium stibogluconate—Blood urea increased—Epirubicin—bone cancer	0.00406	0.00406	CcSEcCtD
Sodium stibogluconate—Sepsis—Methotrexate—bone cancer	0.00398	0.00399	CcSEcCtD
Sodium stibogluconate—Fluid retention—Doxorubicin—bone cancer	0.00377	0.00378	CcSEcCtD
Sodium stibogluconate—Arrhythmia—Cisplatin—bone cancer	0.00375	0.00376	CcSEcCtD
Sodium stibogluconate—Blood urea increased—Doxorubicin—bone cancer	0.00375	0.00376	CcSEcCtD
Sodium stibogluconate—Sepsis—Epirubicin—bone cancer	0.00373	0.00373	CcSEcCtD
Sodium stibogluconate—Phlebitis—Epirubicin—bone cancer	0.00362	0.00363	CcSEcCtD
Sodium stibogluconate—Renal failure acute—Methotrexate—bone cancer	0.00361	0.00362	CcSEcCtD
Sodium stibogluconate—Flatulence—Cisplatin—bone cancer	0.0036	0.00361	CcSEcCtD
Sodium stibogluconate—Sepsis—Doxorubicin—bone cancer	0.00345	0.00346	CcSEcCtD
Sodium stibogluconate—Vision blurred—Cisplatin—bone cancer	0.00345	0.00345	CcSEcCtD
Sodium stibogluconate—Cardiac failure congestive—Epirubicin—bone cancer	0.00344	0.00344	CcSEcCtD
Sodium stibogluconate—Cerebrovascular accident—Methotrexate—bone cancer	0.0034	0.00341	CcSEcCtD
Sodium stibogluconate—Renal failure acute—Epirubicin—bone cancer	0.00338	0.00338	CcSEcCtD
Sodium stibogluconate—Phlebitis—Doxorubicin—bone cancer	0.00335	0.00336	CcSEcCtD
Sodium stibogluconate—Renal impairment—Epirubicin—bone cancer	0.00328	0.00328	CcSEcCtD
Sodium stibogluconate—Cerebrovascular accident—Epirubicin—bone cancer	0.00318	0.00319	CcSEcCtD
Sodium stibogluconate—Cardiac failure congestive—Doxorubicin—bone cancer	0.00318	0.00319	CcSEcCtD
Sodium stibogluconate—Irritability—Methotrexate—bone cancer	0.00318	0.00319	CcSEcCtD
Sodium stibogluconate—Convulsion—Cisplatin—bone cancer	0.00317	0.00317	CcSEcCtD
Sodium stibogluconate—Hyponatraemia—Epirubicin—bone cancer	0.00313	0.00314	CcSEcCtD
Sodium stibogluconate—Renal failure acute—Doxorubicin—bone cancer	0.00313	0.00313	CcSEcCtD
Sodium stibogluconate—Anxiety—Cisplatin—bone cancer	0.0031	0.00311	CcSEcCtD
Sodium stibogluconate—Renal impairment—Doxorubicin—bone cancer	0.00303	0.00304	CcSEcCtD
Sodium stibogluconate—Anaphylactic shock—Cisplatin—bone cancer	0.00298	0.00299	CcSEcCtD
Sodium stibogluconate—Oedema—Cisplatin—bone cancer	0.00298	0.00299	CcSEcCtD
Sodium stibogluconate—Infection—Cisplatin—bone cancer	0.00296	0.00297	CcSEcCtD
Sodium stibogluconate—Cerebrovascular accident—Doxorubicin—bone cancer	0.00294	0.00295	CcSEcCtD
Sodium stibogluconate—Blood creatinine increased—Epirubicin—bone cancer	0.00292	0.00293	CcSEcCtD
Sodium stibogluconate—Tachycardia—Cisplatin—bone cancer	0.00291	0.00292	CcSEcCtD
Sodium stibogluconate—Dehydration—Epirubicin—bone cancer	0.0029	0.00291	CcSEcCtD
Sodium stibogluconate—Hyponatraemia—Doxorubicin—bone cancer	0.0029	0.0029	CcSEcCtD
Sodium stibogluconate—Hyperhidrosis—Cisplatin—bone cancer	0.00289	0.00289	CcSEcCtD
Sodium stibogluconate—Anorexia—Cisplatin—bone cancer	0.00284	0.00285	CcSEcCtD
Sodium stibogluconate—Hypokalaemia—Epirubicin—bone cancer	0.00284	0.00284	CcSEcCtD
Sodium stibogluconate—Hypotension—Cisplatin—bone cancer	0.00279	0.00279	CcSEcCtD
Sodium stibogluconate—Abdominal distension—Epirubicin—bone cancer	0.00271	0.00272	CcSEcCtD
Sodium stibogluconate—Blood creatinine increased—Doxorubicin—bone cancer	0.0027	0.00271	CcSEcCtD
Sodium stibogluconate—Dysphagia—Epirubicin—bone cancer	0.0027	0.0027	CcSEcCtD
Sodium stibogluconate—Dehydration—Doxorubicin—bone cancer	0.00268	0.00269	CcSEcCtD
Sodium stibogluconate—Paraesthesia—Cisplatin—bone cancer	0.00268	0.00268	CcSEcCtD
Sodium stibogluconate—Dyspnoea—Cisplatin—bone cancer	0.00266	0.00267	CcSEcCtD
Sodium stibogluconate—Hypokalaemia—Doxorubicin—bone cancer	0.00263	0.00263	CcSEcCtD
Sodium stibogluconate—Decreased appetite—Cisplatin—bone cancer	0.00259	0.0026	CcSEcCtD
Sodium stibogluconate—Bronchitis—Epirubicin—bone cancer	0.00259	0.0026	CcSEcCtD
Sodium stibogluconate—Renal failure—Methotrexate—bone cancer	0.00252	0.00253	CcSEcCtD
Sodium stibogluconate—Abdominal distension—Doxorubicin—bone cancer	0.00251	0.00252	CcSEcCtD
Sodium stibogluconate—Dysphagia—Doxorubicin—bone cancer	0.00249	0.0025	CcSEcCtD
Sodium stibogluconate—Bronchitis—Doxorubicin—bone cancer	0.0024	0.0024	CcSEcCtD
Sodium stibogluconate—Renal failure—Epirubicin—bone cancer	0.00236	0.00237	CcSEcCtD
Sodium stibogluconate—Body temperature increased—Cisplatin—bone cancer	0.00236	0.00236	CcSEcCtD
Sodium stibogluconate—Hypersensitivity—Cisplatin—bone cancer	0.0022	0.0022	CcSEcCtD
Sodium stibogluconate—Renal failure—Doxorubicin—bone cancer	0.00219	0.00219	CcSEcCtD
Sodium stibogluconate—Hypoaesthesia—Epirubicin—bone cancer	0.00215	0.00215	CcSEcCtD
Sodium stibogluconate—Asthenia—Cisplatin—bone cancer	0.00214	0.00215	CcSEcCtD
Sodium stibogluconate—Diarrhoea—Cisplatin—bone cancer	0.00204	0.00205	CcSEcCtD
Sodium stibogluconate—Hypoaesthesia—Doxorubicin—bone cancer	0.00199	0.00199	CcSEcCtD
Sodium stibogluconate—Dysgeusia—Methotrexate—bone cancer	0.00197	0.00197	CcSEcCtD
Sodium stibogluconate—Arrhythmia—Epirubicin—bone cancer	0.00193	0.00193	CcSEcCtD
Sodium stibogluconate—Vomiting—Cisplatin—bone cancer	0.0019	0.0019	CcSEcCtD
Sodium stibogluconate—Vision blurred—Methotrexate—bone cancer	0.00189	0.00189	CcSEcCtD
Sodium stibogluconate—Rash—Cisplatin—bone cancer	0.00188	0.00189	CcSEcCtD
Sodium stibogluconate—Dermatitis—Cisplatin—bone cancer	0.00188	0.00188	CcSEcCtD
Sodium stibogluconate—Flatulence—Epirubicin—bone cancer	0.00185	0.00185	CcSEcCtD
Sodium stibogluconate—Dysgeusia—Epirubicin—bone cancer	0.00184	0.00184	CcSEcCtD
Sodium stibogluconate—Arrhythmia—Doxorubicin—bone cancer	0.00178	0.00179	CcSEcCtD
Sodium stibogluconate—Nausea—Cisplatin—bone cancer	0.00177	0.00178	CcSEcCtD
Sodium stibogluconate—Vision blurred—Epirubicin—bone cancer	0.00177	0.00177	CcSEcCtD
Sodium stibogluconate—Convulsion—Methotrexate—bone cancer	0.00174	0.00174	CcSEcCtD
Sodium stibogluconate—Flatulence—Doxorubicin—bone cancer	0.00171	0.00172	CcSEcCtD
Sodium stibogluconate—Chest pain—Methotrexate—bone cancer	0.00171	0.00171	CcSEcCtD
Sodium stibogluconate—Dysgeusia—Doxorubicin—bone cancer	0.0017	0.0017	CcSEcCtD
Sodium stibogluconate—Syncope—Epirubicin—bone cancer	0.00168	0.00169	CcSEcCtD
Sodium stibogluconate—Palpitations—Epirubicin—bone cancer	0.00166	0.00166	CcSEcCtD
Sodium stibogluconate—Loss of consciousness—Epirubicin—bone cancer	0.00165	0.00165	CcSEcCtD
Sodium stibogluconate—Anaphylactic shock—Methotrexate—bone cancer	0.00164	0.00164	CcSEcCtD
Sodium stibogluconate—Vision blurred—Doxorubicin—bone cancer	0.00164	0.00164	CcSEcCtD
Sodium stibogluconate—Convulsion—Epirubicin—bone cancer	0.00163	0.00163	CcSEcCtD
Sodium stibogluconate—Infection—Methotrexate—bone cancer	0.00163	0.00163	CcSEcCtD
Sodium stibogluconate—Chest pain—Epirubicin—bone cancer	0.0016	0.0016	CcSEcCtD
Sodium stibogluconate—Anxiety—Epirubicin—bone cancer	0.00159	0.0016	CcSEcCtD
Sodium stibogluconate—Hyperhidrosis—Methotrexate—bone cancer	0.00158	0.00159	CcSEcCtD
Sodium stibogluconate—Anorexia—Methotrexate—bone cancer	0.00156	0.00156	CcSEcCtD
Sodium stibogluconate—Syncope—Doxorubicin—bone cancer	0.00156	0.00156	CcSEcCtD
Sodium stibogluconate—Palpitations—Doxorubicin—bone cancer	0.00154	0.00154	CcSEcCtD
Sodium stibogluconate—Anaphylactic shock—Epirubicin—bone cancer	0.00153	0.00154	CcSEcCtD
Sodium stibogluconate—Oedema—Epirubicin—bone cancer	0.00153	0.00154	CcSEcCtD
Sodium stibogluconate—Hypotension—Methotrexate—bone cancer	0.00153	0.00153	CcSEcCtD
Sodium stibogluconate—Loss of consciousness—Doxorubicin—bone cancer	0.00153	0.00153	CcSEcCtD
Sodium stibogluconate—Infection—Epirubicin—bone cancer	0.00152	0.00153	CcSEcCtD
Sodium stibogluconate—Shock—Epirubicin—bone cancer	0.00151	0.00151	CcSEcCtD
Sodium stibogluconate—Convulsion—Doxorubicin—bone cancer	0.00151	0.00151	CcSEcCtD
Sodium stibogluconate—Tachycardia—Epirubicin—bone cancer	0.0015	0.0015	CcSEcCtD
Sodium stibogluconate—Hyperhidrosis—Epirubicin—bone cancer	0.00148	0.00148	CcSEcCtD
Sodium stibogluconate—Chest pain—Doxorubicin—bone cancer	0.00148	0.00148	CcSEcCtD
Sodium stibogluconate—Anxiety—Doxorubicin—bone cancer	0.00147	0.00148	CcSEcCtD
Sodium stibogluconate—Paraesthesia—Methotrexate—bone cancer	0.00147	0.00147	CcSEcCtD
Sodium stibogluconate—Anorexia—Epirubicin—bone cancer	0.00146	0.00146	CcSEcCtD
Sodium stibogluconate—Dyspnoea—Methotrexate—bone cancer	0.00146	0.00146	CcSEcCtD
Sodium stibogluconate—Hypotension—Epirubicin—bone cancer	0.00143	0.00143	CcSEcCtD
Sodium stibogluconate—Decreased appetite—Methotrexate—bone cancer	0.00142	0.00143	CcSEcCtD
Sodium stibogluconate—Anaphylactic shock—Doxorubicin—bone cancer	0.00142	0.00142	CcSEcCtD
Sodium stibogluconate—Oedema—Doxorubicin—bone cancer	0.00142	0.00142	CcSEcCtD
Sodium stibogluconate—Fatigue—Methotrexate—bone cancer	0.00141	0.00141	CcSEcCtD
Sodium stibogluconate—Infection—Doxorubicin—bone cancer	0.00141	0.00141	CcSEcCtD
Sodium stibogluconate—Shock—Doxorubicin—bone cancer	0.0014	0.0014	CcSEcCtD
Sodium stibogluconate—Tachycardia—Doxorubicin—bone cancer	0.00138	0.00139	CcSEcCtD
Sodium stibogluconate—Paraesthesia—Epirubicin—bone cancer	0.00138	0.00138	CcSEcCtD
Sodium stibogluconate—Hyperhidrosis—Doxorubicin—bone cancer	0.00137	0.00137	CcSEcCtD
Sodium stibogluconate—Dyspnoea—Epirubicin—bone cancer	0.00137	0.00137	CcSEcCtD
Sodium stibogluconate—Anorexia—Doxorubicin—bone cancer	0.00135	0.00135	CcSEcCtD
Sodium stibogluconate—Gastrointestinal pain—Methotrexate—bone cancer	0.00134	0.00134	CcSEcCtD
Sodium stibogluconate—Decreased appetite—Epirubicin—bone cancer	0.00133	0.00133	CcSEcCtD
Sodium stibogluconate—Hypotension—Doxorubicin—bone cancer	0.00133	0.00133	CcSEcCtD
Sodium stibogluconate—Fatigue—Epirubicin—bone cancer	0.00132	0.00132	CcSEcCtD
Sodium stibogluconate—Constipation—Epirubicin—bone cancer	0.00131	0.00131	CcSEcCtD
Sodium stibogluconate—Urticaria—Methotrexate—bone cancer	0.0013	0.0013	CcSEcCtD
Sodium stibogluconate—Abdominal pain—Methotrexate—bone cancer	0.00129	0.0013	CcSEcCtD
Sodium stibogluconate—Body temperature increased—Methotrexate—bone cancer	0.00129	0.0013	CcSEcCtD
Sodium stibogluconate—Paraesthesia—Doxorubicin—bone cancer	0.00127	0.00128	CcSEcCtD
Sodium stibogluconate—Dyspnoea—Doxorubicin—bone cancer	0.00126	0.00127	CcSEcCtD
Sodium stibogluconate—Gastrointestinal pain—Epirubicin—bone cancer	0.00125	0.00126	CcSEcCtD
Sodium stibogluconate—Decreased appetite—Doxorubicin—bone cancer	0.00123	0.00124	CcSEcCtD
Sodium stibogluconate—Fatigue—Doxorubicin—bone cancer	0.00122	0.00122	CcSEcCtD
Sodium stibogluconate—Urticaria—Epirubicin—bone cancer	0.00122	0.00122	CcSEcCtD
Sodium stibogluconate—Constipation—Doxorubicin—bone cancer	0.00121	0.00121	CcSEcCtD
Sodium stibogluconate—Abdominal pain—Epirubicin—bone cancer	0.00121	0.00121	CcSEcCtD
Sodium stibogluconate—Body temperature increased—Epirubicin—bone cancer	0.00121	0.00121	CcSEcCtD
Sodium stibogluconate—Hypersensitivity—Methotrexate—bone cancer	0.00121	0.00121	CcSEcCtD
Sodium stibogluconate—Asthenia—Methotrexate—bone cancer	0.00118	0.00118	CcSEcCtD
Sodium stibogluconate—Gastrointestinal pain—Doxorubicin—bone cancer	0.00116	0.00116	CcSEcCtD
Sodium stibogluconate—Pruritus—Methotrexate—bone cancer	0.00116	0.00116	CcSEcCtD
Sodium stibogluconate—Hypersensitivity—Epirubicin—bone cancer	0.00113	0.00113	CcSEcCtD
Sodium stibogluconate—Urticaria—Doxorubicin—bone cancer	0.00113	0.00113	CcSEcCtD
Sodium stibogluconate—Abdominal pain—Doxorubicin—bone cancer	0.00112	0.00112	CcSEcCtD
Sodium stibogluconate—Body temperature increased—Doxorubicin—bone cancer	0.00112	0.00112	CcSEcCtD
Sodium stibogluconate—Diarrhoea—Methotrexate—bone cancer	0.00112	0.00112	CcSEcCtD
Sodium stibogluconate—Asthenia—Epirubicin—bone cancer	0.0011	0.0011	CcSEcCtD
Sodium stibogluconate—Pruritus—Epirubicin—bone cancer	0.00108	0.00109	CcSEcCtD
Sodium stibogluconate—Dizziness—Methotrexate—bone cancer	0.00108	0.00109	CcSEcCtD
Sodium stibogluconate—Diarrhoea—Epirubicin—bone cancer	0.00105	0.00105	CcSEcCtD
Sodium stibogluconate—Hypersensitivity—Doxorubicin—bone cancer	0.00104	0.00105	CcSEcCtD
Sodium stibogluconate—Vomiting—Methotrexate—bone cancer	0.00104	0.00104	CcSEcCtD
Sodium stibogluconate—Rash—Methotrexate—bone cancer	0.00103	0.00103	CcSEcCtD
Sodium stibogluconate—Dermatitis—Methotrexate—bone cancer	0.00103	0.00103	CcSEcCtD
Sodium stibogluconate—Headache—Methotrexate—bone cancer	0.00103	0.00103	CcSEcCtD
Sodium stibogluconate—Asthenia—Doxorubicin—bone cancer	0.00102	0.00102	CcSEcCtD
Sodium stibogluconate—Dizziness—Epirubicin—bone cancer	0.00101	0.00102	CcSEcCtD
Sodium stibogluconate—Pruritus—Doxorubicin—bone cancer	0.001	0.00101	CcSEcCtD
Sodium stibogluconate—Vomiting—Epirubicin—bone cancer	0.000974	0.000976	CcSEcCtD
Sodium stibogluconate—Nausea—Methotrexate—bone cancer	0.000973	0.000975	CcSEcCtD
Sodium stibogluconate—Diarrhoea—Doxorubicin—bone cancer	0.00097	0.000972	CcSEcCtD
Sodium stibogluconate—Rash—Epirubicin—bone cancer	0.000966	0.000968	CcSEcCtD
Sodium stibogluconate—Dermatitis—Epirubicin—bone cancer	0.000965	0.000967	CcSEcCtD
Sodium stibogluconate—Headache—Epirubicin—bone cancer	0.00096	0.000962	CcSEcCtD
Sodium stibogluconate—Dizziness—Doxorubicin—bone cancer	0.000938	0.00094	CcSEcCtD
Sodium stibogluconate—Nausea—Epirubicin—bone cancer	0.00091	0.000912	CcSEcCtD
Sodium stibogluconate—Vomiting—Doxorubicin—bone cancer	0.000902	0.000903	CcSEcCtD
Sodium stibogluconate—Rash—Doxorubicin—bone cancer	0.000894	0.000896	CcSEcCtD
Sodium stibogluconate—Dermatitis—Doxorubicin—bone cancer	0.000893	0.000895	CcSEcCtD
Sodium stibogluconate—Headache—Doxorubicin—bone cancer	0.000888	0.00089	CcSEcCtD
Sodium stibogluconate—Nausea—Doxorubicin—bone cancer	0.000842	0.000844	CcSEcCtD
Sodium stibogluconate—TOP1—Circadian rythm related genes—TNFRSF11A—bone cancer	0.00038	0.202	CbGpPWpGaD
Sodium stibogluconate—TOP1—Integrated Pancreatic Cancer Pathway—WT1—bone cancer	0.000172	0.0914	CbGpPWpGaD
Sodium stibogluconate—TOP1—Integrated Pancreatic Cancer Pathway—SMO—bone cancer	0.000147	0.0777	CbGpPWpGaD
Sodium stibogluconate—TOP1—Integrated Pancreatic Cancer Pathway—EZH2—bone cancer	0.000133	0.0708	CbGpPWpGaD
Sodium stibogluconate—TOP1—Circadian rythm related genes—GNA11—bone cancer	0.000129	0.0682	CbGpPWpGaD
Sodium stibogluconate—TOP1—Circadian rythm related genes—EZH2—bone cancer	0.000128	0.0679	CbGpPWpGaD
Sodium stibogluconate—TOP1—Integrated Pancreatic Cancer Pathway—IL3—bone cancer	0.000122	0.0645	CbGpPWpGaD
Sodium stibogluconate—TOP1—Integrated Pancreatic Cancer Pathway—CHEK2—bone cancer	0.00012	0.0636	CbGpPWpGaD
Sodium stibogluconate—TOP1—Integrated Pancreatic Cancer Pathway—BRCA2—bone cancer	0.000102	0.0539	CbGpPWpGaD
Sodium stibogluconate—TOP1—Integrated Pancreatic Cancer Pathway—CDK4—bone cancer	7.53e-05	0.04	CbGpPWpGaD
Sodium stibogluconate—TOP1—Circadian rythm related genes—CDK4—bone cancer	7.23e-05	0.0384	CbGpPWpGaD
Sodium stibogluconate—TOP1—Integrated Pancreatic Cancer Pathway—MDM2—bone cancer	5.58e-05	0.0296	CbGpPWpGaD
Sodium stibogluconate—TOP1—Integrated Pancreatic Cancer Pathway—PTGS2—bone cancer	5.38e-05	0.0286	CbGpPWpGaD
Sodium stibogluconate—TOP1—Integrated Pancreatic Cancer Pathway—JUN—bone cancer	4.85e-05	0.0257	CbGpPWpGaD
Sodium stibogluconate—TOP1—Circadian rythm related genes—JUN—bone cancer	4.66e-05	0.0247	CbGpPWpGaD
Sodium stibogluconate—TOP1—Integrated Pancreatic Cancer Pathway—EGFR—bone cancer	3.82e-05	0.0202	CbGpPWpGaD
Sodium stibogluconate—TOP1—Integrated Pancreatic Cancer Pathway—TP53—bone cancer	3.2e-05	0.017	CbGpPWpGaD
Sodium stibogluconate—TOP1—Circadian rythm related genes—TP53—bone cancer	3.08e-05	0.0163	CbGpPWpGaD
